Le Chevalier T - Search Results

1

Developments in the treatment of early NSCLC: when to use chemotherapy.

Besse B, Le Chevalier T. Besse B, et al. Among authors: le chevalier t. Ann Oncol. 2012 Sep;23 Suppl 10:x52-9. doi: 10.1093/annonc/mds347. Ann Oncol. 2012. PMID: 22987993 Free article.

2

Chemokine receptor CXCR4 and early-stage non-small cell lung cancer: pattern of expression and correlation with outcome.

Spano JP, Andre F, Morat L, Sabatier L, Besse B, Combadiere C, Deterre P, Martin A, Azorin J, Valeyre D, Khayat D, Le Chevalier T, Soria JC. Spano JP, et al. Among authors: le chevalier t. Ann Oncol. 2004 Apr;15(4):613-7. doi: 10.1093/annonc/mdh136. Ann Oncol. 2004. PMID: 15033669 Free article.

3

[Neoadjuvant chemotherapy in non small cell lung cancer].

Besse B, Vignot S, Le Chevalier T. Besse B, et al. Among authors: le chevalier t. Bull Cancer. 2006 Nov;93(11):1087-92. Bull Cancer. 2006. PMID: 17145577 Free article. Review. French.

4

Adjuvant or induction cisplatin-based chemotherapy for operable lung cancer.

Besse B, Le Chevalier T. Besse B, et al. Among authors: le chevalier t. Oncology (Williston Park). 2009 May;23(6):520-7. Oncology (Williston Park). 2009. PMID: 19544693 Review.

5

Should surgery be part of the multimodality treatment for stage IIIB non-small cell lung cancer?

Collaud S, Provost B, Besse B, Fabre D, Le Chevalier T, Mercier O, Mussot S, Fadel E. Collaud S, et al. Among authors: le chevalier t. J Surg Oncol. 2018 Jun;117(7):1570-1574. doi: 10.1002/jso.25042. Epub 2018 Mar 24. J Surg Oncol. 2018. PMID: 29573419

6

Front-line doublets in advanced non-small cell lung cancer: The golden age for second line chemotherapy.

Besse B, Soria JC, Le Chevalier T. Besse B, et al. Among authors: le chevalier t. Ann Oncol. 2005 Jul;16(7):997-8. doi: 10.1093/annonc/mdi231. Epub 2005 Jun 9. Ann Oncol. 2005. PMID: 15946975 Free article. No abstract available.

7

Nuclear localization of apoptosis protease activating factor-1 predicts survival after tumor resection in early-stage non-small cell lung cancer.

Besse B, Candé C, Spano JP, Martin A, Khayat D, Le Chevalier T, Tursz T, Sabatier L, Soria JC, Kroemer G. Besse B, et al. Among authors: le chevalier t. Clin Cancer Res. 2004 Sep 1;10(17):5665-9. doi: 10.1158/1078-0432.CCR-04-0415. Clin Cancer Res. 2004. PMID: 15355891

8

Epidermal growth factor receptor, HER-2/neu and related pathways in lung adenocarcinomas with bronchioloalveolar features.

Erman M, Grunenwald D, Penault-Llorca F, Grenier J, Besse B, Validire P, Morat L, Girard P, Le Chevalier T, Sabatier L, Soria JC. Erman M, et al. Among authors: le chevalier t. Lung Cancer. 2005 Mar;47(3):315-23. doi: 10.1016/j.lungcan.2004.08.015. Lung Cancer. 2005. PMID: 15713515

9

Adjuvant chemotherapy for non-small-cell lung cancer: a fading effect?

Besse B, Le Chevalier T. Besse B, et al. Among authors: le chevalier t. J Clin Oncol. 2008 Nov 1;26(31):5014-7. doi: 10.1200/JCO.2008.18.1081. Epub 2008 Sep 22. J Clin Oncol. 2008. PMID: 18809602 No abstract available.

10

An open-label, multicenter, randomized, phase II study of pazopanib in combination with pemetrexed in first-line treatment of patients with advanced-stage non-small-cell lung cancer.

Scagliotti GV, Felip E, Besse B, von Pawel J, Mellemgaard A, Reck M, Bosquee L, Chouaid C, Lianes-Barragán P, Paul EM, Ruiz-Soto R, Sigal E, Ottesen LH, Lechevalier T. Scagliotti GV, et al. J Thorac Oncol. 2013 Dec;8(12):1529-37. doi: 10.1097/JTO.0000000000000005. J Thorac Oncol. 2013. PMID: 24389434 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

334 results

Search Page

Filters